<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>86(1)</volume><submitter>de Jong LAW</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>In this exploratory study, the effect of postprocedural flushing with crystalloids after oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) on platinum concentrations in peritoneal tissue, blood, and drain fluid was studied. Interpatient variability in oxaliplatin pharmacokinetics and the relation between platinum concentration in peritoneal fluid and platinum exposure in tissue and blood was explored.&lt;h4>Methods&lt;/h4>Ten patients with peritoneal carcinomatosis of colorectal origin were treated with HIPEC including postprocedural flushing, followed by ten patients without flushing afterwards. Tissue, peritoneal fluid, blood, and drain fluid samples were collected for measurement of total and ultrafiltered platinum concentrations.&lt;h4>Results&lt;/h4>Peritoneal ti</pubmed_abstract><journal>Cancer chemotherapy and pharmacology</journal><pagination>141-150</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7338818</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.</pubmed_title><pmcid>PMC7338818</pmcid><pubmed_authors>Lambert M</pubmed_authors><pubmed_authors>Elekonawo FMK</pubmed_authors><pubmed_authors>van Erp NP</pubmed_authors><pubmed_authors>Verheul HMW</pubmed_authors><pubmed_authors>de Jong LAW</pubmed_authors><pubmed_authors>de Gooyer JM</pubmed_authors><pubmed_authors>de Reuver PR</pubmed_authors><pubmed_authors>Bremers AJA</pubmed_authors><pubmed_authors>de Wilt JHW</pubmed_authors><pubmed_authors>Ter Heine R</pubmed_authors><pubmed_authors>Burger DM</pubmed_authors><pubmed_authors>Chatelut E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.</name><description>&lt;h4>Purpose&lt;/h4>In this exploratory study, the effect of postprocedural flushing with crystalloids after oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) on platinum concentrations in peritoneal tissue, blood, and drain fluid was studied. Interpatient variability in oxaliplatin pharmacokinetics and the relation between platinum concentration in peritoneal fluid and platinum exposure in tissue and blood was explored.&lt;h4>Methods&lt;/h4>Ten patients with peritoneal carcinomatosis of colorectal origin were treated with HIPEC including postprocedural flushing, followed by ten patients without flushing afterwards. Tissue, peritoneal fluid, blood, and drain fluid samples were collected for measurement of total and ultrafiltered platinum concentrations.&lt;h4>Results&lt;/h4>Peritoneal ti</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-04T03:24:41.05Z</modification><creation>2021-02-20T07:30:42Z</creation></dates><accession>S-EPMC7338818</accession><cross_references><pubmed>32594200</pubmed><doi>10.1007/s00280-020-04107-y</doi></cross_references></HashMap>